CIK 0001726445
- Non-accelerated filer
- Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821153150
- Phone
- +1 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- 4 Open-market sale PRESIDENT & CFO sold 6,797 shares at $1.97 ($13,400)
- 4 Open-market sale CEO AND CHAIR sold 33,838 shares at $1.97 ($66,708)
- 4 Grant or award Director acquired 41,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale PRESIDENT & CFO sold 6,827 shares at $2.04 ($13,955)
- 4 Open-market sale CEO AND CHAIR sold 33,992 shares at $2.04 ($69,483)
- 4 Grant or award Director acquired 17,083 shares (grant or award)
- 4 Grant or award Director acquired 20,500 shares (grant or award)
- 4 Grant or award Director acquired 20,500 shares (grant or award)
- 4 Grant or award Director acquired 20,500 shares (grant or award)
- 4 Grant or award Director acquired 20,500 shares (grant or award)
- 4 Planned sale Director sold 30,253 shares at $2.08 ($62,935)
- 4 Open-market sale PRESIDENT & CFO sold 6,760 shares at $2.08 ($14,028)
- 4 Open-market sale CEO AND CHAIR sold 33,663 shares at $2.08 ($69,854)
- 4 Shares withheld for taxes PRESIDENT & CFO gave up 26,572 shares (to pay taxes)
- 4 Shares withheld for taxes CEO AND CHAIR gave up 88,494 shares (to pay taxes)
- 4 Open-market sale PRESIDENT & CFO sold 3,550 shares at $2.24 ($7,940)
- 4 Open-market sale CEO AND CHAIR sold 8,068 shares at $2.24 ($18,044)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 9 · 166 filings